IL6pro-Luc/EF1α-mCherry Reporter Cell Line - HeLa

IL6pro-Luc/EF1α-mCherry Reporter Cell Line - HeLa is a dual-reporter human cervical cancer cell line engineered to provide sensitive monitoring of interleukin-6 (IL-6) promoter activity. The cells carry a firefly luciferase reporter driven by the human IL6 promoter (IL6pro-Luc), enabling quantitative detection of transcriptional activation through luminescence measurement. In parallel, constitutive expression of mCherry under the EF1α promoter provides a stable red fluorescent marker for cell identification, visualization, and normalization of cell number or transfection-related variation. Based on the HeLa background, this reporter cell line retains the robust growth characteristics and experimental convenience associated with HeLa cells, making it suitable for reproducible cell-based assays. IL-6 is a key pro-inflammatory cytokine involved in immune regulation, infection, tissue injury, tumor progression, and chronic inflammatory disorders; therefore, promoter-driven luciferase activity offers a direct readout of regulatory events affecting IL6 gene expression.

This cell line is particularly useful for studying signaling pathways and molecular mechanisms that regulate IL-6 production. It can be applied to evaluate inflammatory stimuli, including cytokines, pathogen-associated components, oxidative stress, and other agents that activate pathways such as NF-κB, MAPK, AP-1, and related transcriptional networks. The luminescent signal supports sensitive, scalable, and quantitative analysis in compound screening programs aimed at identifying inhibitors or activators of IL-6 transcription. Meanwhile, EF1α-driven mCherry fluorescence facilitates routine monitoring of cell status, imaging-based assays, and normalization across treatment groups. The reporter system can also be used to characterize gene overexpression, gene knockdown, CRISPR-mediated perturbation, or promoter-targeting strategies that influence IL6 promoter activity. Its combined luciferase and fluorescent readouts make the cell line a practical tool for inflammation research, oncology studies, immunomodulatory drug discovery, and functional validation of candidate therapeutic targets.